← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 1, 2010Last known activity
Dec 31, 2022
Timeline
2000s
- Jun 1, 2005
Mersana Therapeutics— Founded
Drugs by trial phase (8 distinct, 10 trials)
Indications
Recent trials (18)
- NCT05514717Lead sponsorPhase 1Dec 31, 2022
- NCT05514717Study directorPhase 1Dec 31, 2022
- NCT05377996Lead sponsorPhase 1Aug 15, 2022
- NCT05377996Study directorPhase 1Aug 15, 2022
- NCT04907968Lead sponsorPhase 1/Phase 2Jun 11, 2021
- NCT04907968Study directorPhase 1/Phase 2Jun 11, 2021
- NCT04396340Lead sponsorPhase 1/Phase 2May 11, 2020
- NCT04396340Study directorPhase 1/Phase 2May 11, 2020
- NCT06517485OfficialPhase 1Jul 30, 2019
- NCT06517485Lead sponsorPhase 1Jul 30, 2019
- NCT06517433OfficialPhase 1Dec 12, 2017
- NCT03319628Study directorPhase 1Dec 12, 2017
- NCT03319628Lead sponsorPhase 1Dec 12, 2017
- NCT06517433Lead sponsorPhase 1Dec 12, 2017
- NCT02952729Lead sponsorPhase 1Nov 1, 2016
Details
- Founded
- Cambridge, MA, US Jun 1, 2005
- Last known activity
- Dec 31, 2022